Tripathi Lab for Cancer and Deubiquitinase Biology
Tripathi Lab for Cancer and Deubiquitinase Biology
Our lab at Department of Biotechnology at M.S. Ramaiah University of Applied Sciences (RUAS), Bengaluru, India, is interested in understanding how the ubiquitin signaling regulates cancer development and progression.
Protein ubiquitination is a fundamental cellular process that controls protein stability, localization, and function. Disruption of this pathway contributes to numerous human diseases, particularly cancer. Our research focuses on deubiquitinating enzymes (DUBs), a family of enzymes that remove ubiquitin from target proteins and thereby regulate key oncogenic signaling pathways. Since DUBs are enzymatically targetable, they represent promising candidates for the development of next-generation cancer therapeutics.
Our laboratory integrates CRISPR/Cas9-based genetic screening, molecular and cellular biology, and bioinformatics to uncover novel DUB-mediated regulatory mechanisms in cancer. We are particularly interested in understanding how DUBs control major hallmarks of cancer, including metastasis, telomerase activation, metabolic reprogramming, cancer stemness, therapy resistance, and radioresistance. Alongside mechanistic studies, we are actively pursuing the discovery and development of small-molecule inhibitors targeting clinically relevant DUBs for cancer therapy.
PhD Positions Available
We invite motivated and enthusiastic students interested in pursuing doctoral research in cancer biology, ubiquitin signalling, and deubiquitinase biology to join the Tripathi Lab.